
DS-1205
CAS No. 1855860-24-0
DS-1205( —— )
Catalog No. M28589 CAS No. 1855860-24-0
DS-1205 is a potent and selective inhibitor of AXL kinase, with an IC50 of 1.3 nM. DS-1205 also inhibits MER, MET, and TRKA, with IC50s of 63, 104, and 407 nM, respectively. DS-1205 can inhibit cell migration in vitro and tumor growth in vivo.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 305 | Get Quote |
![]() ![]() |
10MG | 500 | Get Quote |
![]() ![]() |
25MG | 807 | Get Quote |
![]() ![]() |
50MG | 1107 | Get Quote |
![]() ![]() |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameDS-1205
-
NoteResearch use only, not for human use.
-
Brief DescriptionDS-1205 is a potent and selective inhibitor of AXL kinase, with an IC50 of 1.3 nM. DS-1205 also inhibits MER, MET, and TRKA, with IC50s of 63, 104, and 407 nM, respectively. DS-1205 can inhibit cell migration in vitro and tumor growth in vivo.
-
DescriptionDS-1205 is a potent and selective inhibitor of AXL kinase, with an IC50 of 1.3 nM. DS-1205 also inhibits MER, MET, and TRKA, with IC50s of 63, 104, and 407 nM, respectively. DS-1205 can inhibit cell migration in vitro and tumor growth in vivo.(In Vitro):DS-1205 (0.3-33 μM; 2-24 h) inhibits hGAS6-induced migration in NIH3T3-AXL cells (EC50=2.7 nM). DS-1205 (1-10000 μM; 2-24 h) significantly inhibits the phosphorylation of AXL in NIH3T3-AXL cells. DS-1205 decreases NIH3T3 cell proliferation but not obviously inhibits growth (GI50>10,000 nM).(In Vivo):DS-1205 (3.1-50 mg/kg; p.o. bid for 5 d) exhibits pAXL inhibition mediated antitumor effects in mice.
-
In VitroDS-1205b (0.3-33 μM; 2-24 h) inhibits hGAS6-induced migration in NIH3T3-AXL cells (EC50=2.7 nM).DS-1205b (1-10000 μM; 2-24 h) significantly inhibits the phosphorylation of AXL in NIH3T3-AXL cells. DS-1205b decreases NIH3T3 cell proliferation but not obviously inhibits growth (GI50>10,000 nM). Western Blot Analysis Cell Line:NIH3T3-AXL cells Concentration:1, 10, 100, 1000, 10000 μM Incubation Time:2, 24 hours Result:Completely inhibited the phosphorylation of AXL at concentrations above 10 nM.Slightly inhibited the phosphorylation of AKT serine/threonine kinase in a dose-dependent manner.
-
In VivoDS-1205b (3.1-50 mg/kg; p.o. bid for 5 d) exhibits pAXL inhibition mediated antitumor effects in mice. Animal Model:Female NOD/Shi-scid IL-2Rγ KO Jic mice were implanted with NIH3T3-AXL tumor blocks Dosage:3.1, 6.3, 13, 25, 50 mg/kg Administration:P.o. twice daily for 5 days Result:Inhibited tumor growth by 39-94%.Reduced the phosphorylation of both AXL and AKT in tumors.
-
Synonyms——
-
PathwayTyrosine Kinase
-
TargetTAM Receptor
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1855860-24-0
-
Formula Weight284.32
-
Molecular FormulaC14H16N6O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (67.95 mM)
-
SMILESNc1nonc1-c1nc(cncc2)c2n1C1CCCCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Allmann TC, et al. Synthesis of Hydroxypyrrolone Carboxamides Employing Selectfluor. Chemistry. 2016 Jan 4;22(1):111-5.
molnova catalog



related products
-
Enapotamab
Enapotamab is an AXL/UFO-related antibody that can be used to synthesize antibody-drug couplings (Enapotamab Vedotin).
-
Ningetinib Tosylate
Ningetinib Tosylate is an orally bioavailable tyrosine kinase inhibitor with IC50s of <1.0, 1.9 and 6.7 nM for Axl, VEGFR2, and c-Met, respectively.
-
UNC2541
UNC2541 is a potent and Mer tyrosine kinase (MerTK)-specific inhibitor. It also binds in the MerTK ATP pocket (IC50: 4.4 nM).